APP and Alzheimer disease: Pharmacological inhibition of PERK in AD models (e.g., rTg4510 tau mice) restores neuronal protein synthesis and mitigates neurodegeneration [85], while ATF4 knockdown in PSEN1/APP mice preserves cholinergic neurons [86].